This announcement is a separate document:
卫信康:西藏卫信康医药股份有限公司2024年前三季度权益分派实施公告
Wei Xinkang: Announcement on the implementation of equity allocation for the first three quarters of 2024 by Tibet Weixinkang Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.